Updates on the Treatment Approach for MCL

 

Updates on the Treatment Approach for MCL
09:38

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Outcomes of Adults With R/R B-ALL Treated With Brexu-Cel in ZUMA-3 - Impact of Age, Prior Therapies, and Subsequent Transplant"

FEATURING Bijal Shah
  • 176 views
  • June 7, 2023
  • 5
15:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clinical Perspectives on Nivo-AVD vs. BV-AVD in Advanced Stage cHL"

FEATURING Andrew Evens
  • 820 views
  • June 9, 2023
  • 4
11:12

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AVD vs. Brentuximab Vedotin-AVD in Advanced Stage cHL"

FEATURING Alex Herrera
  • 1,112 views
  • June 8, 2023
  • 13
09:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Randomized ZUMA‑7 Study of Axi-Cel vs. Standard‑of-Care Therapy in R/R LBCL"

FEATURING Jason Westin
  • 1,437 views
  • June 7, 2023
  • 3
09:45

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary Refractory/Early Relapsed DLBCL"

FEATURING Manali Kamdar
  • 625 views
  • June 7, 2023
  • 1
34:28

Indy Hematology Review

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

FEATURING Tycel Phillips
  • 129 views
  • April 19, 2023
  • 1
07:08

VCU Massey Cancer Center

Recent Advances in the Treatment of MCL

FEATURING Victor Yazbeck
  • 159 views
  • May 8, 2023
38:55

Indy Hematology Review

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellular Therapies in 2023

FEATURING Gilles Salles
  • 140 views
  • April 18, 2023
  • 1
10:51

Kami Maddocks

Sequencing Treatment for R/R MCL

  • 88 views
  • April 28, 2023
29:22

UChicago Medicine

Updates on MCL and CAR-T

FEATURING Peter Riedell
  • 45 views
  • April 28, 2023
  • 1
09:00

Thomas McFarlane

Targeting and Treatment of MCL

  • 92 views
  • April 25, 2023
  • 1
24:04

Yale Cancer Center

Updates on Allogeneic Stem Cell Transplant

FEATURING Lohith Bachegowda
  • 101 views
  • April 13, 2023
  • 2
11:19

The University of Alabama at Birmingham School of Medicine

Mantle Cell Lymphoma: Unmet Needs & Latest Therapeutical Insights

FEATURING Amitkumar Mehta
  • 130 views
  • April 3, 2023
12:54

The University of Alabama at Birmingham School of Medicine

Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing Considerations

FEATURING Mayur Narkhede
  • 296 views
  • March 22, 2023
  • 2
15:01

Yazeed Sawalha

Novel Combinations for the Treatment of Patients With R/R MCL: Promising and Feasible Treatment Options

  • 42 views
  • April 5, 2023
19:16

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Chemo and Non-Chemo Treatment of Mantle Cell Lymphoma

FEATURING Michael Wang
  • 188 views
  • April 6, 2023
09:47

Icahn School of Medicine at Mount Sinai

What's the Difference? Covalent vs. Non-Covalent BTKis in MCL

FEATURING Joshua Brody
  • 53 views
  • April 5, 2023
  • 1
05:24

Chan Cheah

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Additional Patients and Extended Follow-Up From the Phase 1/2 BRUIN Study

  • 456 views
  • March 22, 2023
  • 3
25:29

19th Annual International Ultmann Chicago Lymphoma Symposium

Mantle Cell Lymphoma: Case-Based Approach to Management

FEATURING Reem Karmali
  • 524 views
  • July 11, 2022
  • 5
07:11

Lauren Pinter-Brown

Disease Progression in Mantle Cell Lymphoma

  • 291 views
  • October 11, 2022
  • 1
07:48

City of Hope

Tolerability of BTKi in R/R MCL

FEATURING Tycel Phillips
  • 193 views
  • October 12, 2022
  • 1
10:36

ASH 2022 Conference Coverage

The CAR-HEMATOTOX Score Identifies Patients at High Risk for Hematological Toxicity, Infections, and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in R/R MCL

FEATURING Kai Rejeski
  • 109 views
  • December 21, 2022
12:42

University of Colorado Cancer Center

Management of Patients With R/R MCL

FEATURING Manali Kamdar
  • 213 views
  • October 11, 2022
06:35

ASH 2022 Conference Coverage

Results From a Phase 1/2 Study of Tandem, Bispecific Anti-CD20/Anti-CD19 (LV20.19) CAR T-Cells for MCL

FEATURING Nirav Shah
  • 136 views
  • December 21, 2022
08:54

ASH 2022 Conference Coverage

ECOG-ACRIN E1411: A Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab Based Induction Followed by Rituximab ± Lenalidomide Consolidation for MCL

FEATURING Mitchell Smith
  • 106 views
  • January 4, 2023
  • 1
06:16

City of Hope

Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma

FEATURING Alexey Danilov
  • 148 views
  • January 11, 2023
  • 1